DE602004024586D1 - Verwendung von ziegenserum zur veterinärmedizinischen behandlung - Google Patents

Verwendung von ziegenserum zur veterinärmedizinischen behandlung

Info

Publication number
DE602004024586D1
DE602004024586D1 DE602004024586T DE602004024586T DE602004024586D1 DE 602004024586 D1 DE602004024586 D1 DE 602004024586D1 DE 602004024586 T DE602004024586 T DE 602004024586T DE 602004024586 T DE602004024586 T DE 602004024586T DE 602004024586 D1 DE602004024586 D1 DE 602004024586D1
Authority
DE
Germany
Prior art keywords
veterinary treatment
goat serum
treatment
medicament
veterinary
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602004024586T
Other languages
English (en)
Inventor
Graham Joseph Peck
Juliette Peck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aimsco Ltd
Original Assignee
Aimsco Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0328650A external-priority patent/GB0328650D0/en
Priority claimed from GB0404533A external-priority patent/GB0404533D0/en
Priority claimed from GB0404534A external-priority patent/GB0404534D0/en
Application filed by Aimsco Ltd filed Critical Aimsco Ltd
Publication of DE602004024586D1 publication Critical patent/DE602004024586D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/42—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39516—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum from serum, plasma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2833—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against MHC-molecules, e.g. HLA-molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE602004024586T 2003-12-11 2004-12-10 Verwendung von ziegenserum zur veterinärmedizinischen behandlung Active DE602004024586D1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0328650A GB0328650D0 (en) 2003-12-11 2003-12-11 Treatment equines
GB0404533A GB0404533D0 (en) 2004-03-01 2004-03-01 Treatment of canines
GB0404534A GB0404534D0 (en) 2004-03-01 2004-03-01 Treatment of canines
PCT/GB2004/050040 WO2005056053A1 (en) 2003-12-11 2004-12-10 Use of goat serum for veterinary treatment

Publications (1)

Publication Number Publication Date
DE602004024586D1 true DE602004024586D1 (de) 2010-01-21

Family

ID=34681900

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004024586T Active DE602004024586D1 (de) 2003-12-11 2004-12-10 Verwendung von ziegenserum zur veterinärmedizinischen behandlung

Country Status (11)

Country Link
US (5) US20080031885A1 (de)
EP (2) EP1708753B1 (de)
AT (1) ATE451120T1 (de)
AU (2) AU2004296610B2 (de)
CA (1) CA2548901C (de)
DE (1) DE602004024586D1 (de)
DK (1) DK1708753T3 (de)
ES (1) ES2337795T3 (de)
NZ (2) NZ547846A (de)
PL (1) PL1708753T3 (de)
WO (1) WO2005056053A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2013282995B2 (en) 2012-06-25 2018-10-04 Aimsco Limited Formulation comprising CRH and alpha - 2 - immunoglobulin
GB201408171D0 (en) * 2014-05-08 2014-06-25 Aimsco Ltd Formulation and method of manufacture
RU2765542C1 (ru) * 2021-07-08 2022-01-31 федеральное государственное автономное образовательное учреждение высшего образования "Российский университет дружбы народов" (РУДН) Способ прогнозирования степени тяжести острого бактериального холангиогепатита у кошек

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5952194A (en) * 1996-08-01 1999-09-14 Heska Corporation Flea nucleic acid sequences and uses thereof
MXPA04007311A (es) * 2002-01-28 2005-05-16 Aimsco Ltd Tratamiento de ms con suero de cabra.
US20060059502A1 (en) * 2003-01-14 2006-03-16 Vroomen Hubert Gerard Jean J A Machine suitable for placing a component on a substrate, as well as a method therefor

Also Published As

Publication number Publication date
EP2177231A2 (de) 2010-04-21
AU2004296610A1 (en) 2005-06-23
AU2004296610B2 (en) 2010-04-01
NZ577823A (en) 2011-03-31
NZ547846A (en) 2009-07-31
ATE451120T1 (de) 2009-12-15
EP1708753B1 (de) 2009-12-09
US20120294951A1 (en) 2012-11-22
US8617553B2 (en) 2013-12-31
CA2548901A1 (en) 2005-06-23
US20080031885A1 (en) 2008-02-07
AU2010202668A1 (en) 2010-07-15
PL1708753T3 (pl) 2010-07-30
US20140178406A1 (en) 2014-06-26
CA2548901C (en) 2015-07-28
ES2337795T3 (es) 2010-04-29
EP1708753A1 (de) 2006-10-11
DK1708753T3 (da) 2010-04-26
EP2177231A3 (de) 2012-08-15
AU2010202668B2 (en) 2012-05-24
US20110244053A1 (en) 2011-10-06
US20090202522A1 (en) 2009-08-13
WO2005056053A1 (en) 2005-06-23

Similar Documents

Publication Publication Date Title
ATE418271T1 (de) Verfahren zur verringerung des exkrementgeruchs von heimtieren
DE60113301D1 (de) Gel für die Behandlung von Katzen und Hunden
ATE542434T1 (de) Haustierfutterzusammensetzung zur behandlung der helicobacter spezies in haustieren
BRPI0410289A (pt) ligantes do receptor de canabinóides e suas utilizações
ATE484201T1 (de) Verwendung von beta-cryptoxanthin
DE60214080D1 (de) Medizinische Verwendung thyromimetischer Verbindungen gegen Haarausfall und Zusammensetzungen
ATE384437T1 (de) N-thio-nicotinamid derivate und verwandte verbindungen zur verwendung als schädlingsbekämpfungsmittel
DE60307249D1 (de) Eisen-dextrin verbindung zur behandlung von anämien durch eisenmangel
DE60302814D1 (de) Vorrichtung für eine tierbezogene Handlung
DE60130661D1 (de) Verwendung der 13-cis retinsäure zur behandlung von emphysemen
DE602004024586D1 (de) Verwendung von ziegenserum zur veterinärmedizinischen behandlung
DE602005023155D1 (de) Behandlung von amyotrohper lateralsklerose
DE60325496D1 (de) Verwendung von dihydroimidazolonen zur behandlung von epilepsie bei hunden
DK1833308T3 (da) Ögning af proteinandelen af dyriske organismer
DE602006016413D1 (de) Kim-1-antikörper zur behandlung von th2-vermittelten erkrankungen
ATE475325T1 (de) Tierfutterzusammensetzung zur verbesserung von kolostrum
ATE342372T1 (de) Verfahren zur herstellung von d-pantothensäure und/oder deren salze als zusatz zu tierfuttermitteln
ATE349544T1 (de) Verfahren zur herstellung von d-pantothensäure und/oder deren salze als zusatz zu tierfuttermitteln
DE602004011254D1 (de) Kennzeichnungssystem mit wegwerf-injektor
DE60219495D1 (de) Verwendung von Interleukin-18 zur Behandlung von UV-assoziierten Hautkrankheiten
DE60215594D1 (de) Auswertung von Agenzien zur Behandlung von Schizophrenie
DK1670309T3 (da) Transgenetiske dyr med større lidelser i forbindelse med Alzheimers sygdom
DE60315376D1 (de) Vorrichtung zur Behandlung von Erntegut
ATE488606T1 (de) Chemische behandlung von tierhäuten
DE112022002673A5 (de) Vorrichtung zur pflege von tieren, insbesondere von hauskatzen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition